An expert Q&A with Kenneth Schacter and Mary Gail Gearns explaining the standard for assessing the admissibility of expert testimony under the US Supreme Court's decision in Daubert v. Merrell Dow Pharmaceuticals, Inc. and its progeny, and examining key issues, trends and strategic considerations associated with Daubert challenges.